Skip to main content
. 2012 Sep 12;13(6):771–783. doi: 10.1007/s10162-012-0347-y

TABLE 1.

Pharmacokinetic parameters derived by simulation

Substance n Injection Time (min) Delay Time (min) ST elimination half-time (min) SV/ SM elimination Half-time (min) SCC elimination half-time (min) CSF influx rate (nl/min)
TMPA 5 30 120 29 172 170 0.058
TMPA 3 60 120 40 620 64 0.025
TMPA 3 90 120 38.9 188 256 0.059
TMPA 5 30 30 14 250 100 0.060
TMPA 3 30 60 13 2200 85 0.075
TMPA 3 30 180 36.4 241 102 0.100
TMPA 1 30 240 39.5 175 135 0.055
Average TMPA 24.5 259 109 0.062
 
Fluorescein 3 60 60 55 None 600 0.070
Fluorescein 4 60 120 58 3800 250 0.060
Fluorescein 3 60 240 50 680 262 0.095
Average Fluorescein 54.1 1730 316 0.075
 
mDex 3 60 60 33.2 90 89 0.010
mDex 3 60 120 18.8 125 55 0
mDex 3 60 240 20.0 126 130 0
Average mDex 22.5 110.9 80.8 0.003
 
Dex P 1 30 120 16 1250 1000 0.09
Dex-P 1 30 180 20 212 170 0.14
Dex-P 1 30 180 19.5 209 167 0.06
Average DexP 18.3 291.2 233 0.097

This analysis shows that elimination rates are different in ST and SV. As half-times are typically not normally distributed, the average half-time shown is calculated as loge(2)/k, where k is the average of the individually-calculated rate constants, each calculated as loge(2)/half-time